Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 20 Biotech Startup Investors in Taiwan in December 2024

Last updated: Dec 2024 A list of 20 angel investors and VC (Venture Capital) funds that invest in Biotech startups based in Taiwan. We rank investors based on the number of investments they made in Biotech companies from Taiwan. We update this investor list every month.

Top 20 Biotech Startup Investors in Taiwan in December 2024

Investor	Biotech Taiwan investments
Darwin Venture Management	4
Translink Capital	3
WI Harper Group	2
National Development Fund of Taiwan Government	2
NCTU Angel Club	2
Verge HealthTech Fund	2
China Development Industrial Bank (CDIB)	2
Might Electronic	1
Taiwania Capital Management Corporation	1
BE Healthcare Ventures	1
Biomark Capital	1
CDIB Capital	1
DCI Partners	1
Mega International Commercial Bank	1
Pangu Venture Capital	1
Bill Chang	1
TaiAn Technologies	1
Lippo Group	1
TMI Holding Corp.	1
John Hsuan	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Darwin Venture Management is a venture capital firm headquartered in Taipei, Taiwan, with offices in Hsinchu and the United States. Since our founding in 2009, we have managed eight funds, investing primarily in Series A/B, late-stage, and secondary funds. In 2022, we also launched an evergreen angel fund to enable more nimble bets onpromising early-stage teams, and especially those coming from Taiwan’s superb academic and research institutions. This exposure across stages and borders, coupled with the strong technical background of our team, is the source of Darwin’s differentiation. We recently launched our 8th fund Darjune.

Investment focus

Software, Manufacturing, Information Technology
Funding Round, Seed, Series A
Taiwan, United States, China

Portfolio highlights

PopChill — PopChill generates an online marketplace for second-hand trade, enabling users to share their fashion styles and sell idle items.
Zehitomo — Zehitomo is an Japanese online platform that enables user to hire local service professionals, from photographers to personal trainers.
Camlann — We're Camlann Games, an indie game publisher that performs. We back passionate developers, vibrant worlds, and the most unforgettable stories ever told.

Translink Capital is a trailblazing Silicon Valley VC with unmatched institutional connections to Asia's economic powerhouses.

Investment focus

Software, Information Technology, Artificial Intelligence
Series A, Series B, Series C
United States, China, South Korea

Portfolio highlights

Uplimit — Unlock the potential of your organization with scalable, high-impact learning experiences.
Sakana AI — We are creating a new kind of foundation model based on nature-inspired intelligence.
TensorWave — Access AMD MI300X GPUs today on TensorWave Cloud. Contact us today to get started.

WI Harper Group is a venture capital firm that focuses on early and early expansion investments in Mainland China, Taiwan and Silicon Valley.It was founded in 1993. Made 300+ investments with 80+ exits. Manages 9 funds and over $1B in capital through 19 dedicated investment professionals located in Beijing, Taipei and San Francisco.Thefirm's focus is technology, clean technology and healthcare. Its track record includes

Investment focus

Software, Health Care, Biotechnology
Series A, Seed, Series B
United States, Taiwan, China

Portfolio highlights

GDMC — GDMC is a pharmaceutical company that engages in manufacturing and designing genetic medicines.
Bitmark — Bitmark develops technology that secures the property rights of unique digital assets, without relying on trusted third parties.
Blackpanda — Asia's premier digital forensics and cyber incident response firm.

The national development fund is the management unit of the non-business cycle budget fund, which is tasked with grouping. It aims to accelerate the industrial innovation value-added, promote economic transformation and national development, and help china's industrial innovation value-added, research and development and self-owned brands. Thefinancing method or assisting the competent authorities of the central government to handle the relevant plans to complete the purposes specified in article 30 of the "industry innovation ordinance".

Investment focus

Software, Information Technology, Health Care
Seed, Series A, Series B
Taiwan, China, Japan

Portfolio highlights

ensage — ensage aggregates quality sports services to create picturesque tour experiences. Start your trips with our variety packages and professional support van drivers.
PopChill — PopChill generates an online marketplace for second-hand trade, enabling users to share their fashion styles and sell idle items.
AnBogen Therapeutics — Harness the Power of Science to Cure Cancer.

NCTU Angel Club is an angel investment group that encourages an aspiring young person to start a business.

Investment focus

Medical, Health Care, Biotechnology
Seed, Series A
Taiwan, United States

Portfolio highlights

MoBagel — MoBagel’s vision is to bring AI-driven decision making to enterprises through software and services. MoBagel has empowered global enterprises to extract business insights and create value from their data across industries including retail, telecom, manufacturing, banking, and more.
Hukui Bio — Founded in November 2013, HuKui Bio provides total solution and value-added services to global medical devices customers. By focusing on medical electronics and handheld devices for digital healthcare and telemedicine, we do the designing and development in Taiwan, manufacturing in Asia, and delivering our sales & services globally. Combiningseasoned experts and investors from biomedical, tech, and financial industries, we strive to be the best partner in the Asia-Pacific region for MedTech developers, startups and corporates by completing projects on-time, on-budget and by meeting global quality standards concurrently. Our US company, HuKui Tech, is a subsidiary based in the Bay area, 100% owned by HuKui Bio since 2020.
Iweecare — Founded in Taiwan Taipei 2014, iWEECARE is collaborating with electronics manufacturers and TSMT (Taiwan Surface Mounting Technology) to create the best user friendly product- Temp Pal® All their team members are parents and expecting couples, who have experienced the morning hassle of checking BBT (Basic Body Temperature) chart and sleeplessnights worrying about child fever. That’s why they put their engineering and medical expertise to developing Temp Pal®, a device designed to make temperature monitoring easier and more comfortable.

We make early investments in global healthcare technology companies that address prevention, disease management and health system efficiency that are relevant to emerging AsiaThey believe that innovation can happen anywhere, from the streets of Dhaka to the labs of Oxford, however without the right support network, these solutions might notscale, or find the best world-changing application. This is where they can help.

Investment focus

Health Care, Medical, Medical Device
Seed, Pre-Seed, Funding Round
Singapore, Estonia, Canada

Portfolio highlights

RetiSpec — RetiSpec is a medical imaging company using advanced AI for the detection of neurodegenerative diseases through hyperspectral imaging of the eye.
BrainCapture — BrainCapture's BC-1 provides the tools to deploy high-quality EEG at the point-of-care.
Pathway Medical — Pathway is an accurate and efficient point-of-care reference tool that gives you rapid access to evidence-based guideline summaries, interactive algorithms, key findings from landmark trials, clinical calculators, and more. Available anytime, anywhere.

CDIB pioneered venture capital and investment banking in Taiwan and today it remains the predominant leader in venture capital business in Taiwan with a market share of over 30%. Along with Taiwan's industrial development, CDIB has built up a wealth of experience in high-tech investment while its investment overseas has extended to the US,Japan, Korea and S.E. Asia.

Investment focus

Biotechnology, Health Care, Medical
Series B, Funding Round, Series A
United States, Taiwan, China

Portfolio highlights

Eden Biologics — Eden Biologics, formerly known as JHL Biotech ("JHL") , is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners through the provision of contract development and manufacturing services. We are specialists in manufacturing biologics, from cell line development tocommercial manufacturing with both global and regional regulatory affairs expertise.
AnBogen Therapeutics — Harness the Power of Science to Cure Cancer.
Elixiron Immunotherapeutics — Elixiron Immunotherapeutics is a company developing therapeutics for cancer, neurological diseases, and inflammatory disorders.

Matt Electronics provides one-stop services from product development, design verification, small-scale trial production, mass production to international logistics.

Investment focus

Medical, Health Care, Biotechnology
Seed
Taiwan

Portfolio highlights

Iweecare — Founded in Taiwan Taipei 2014, iWEECARE is collaborating with electronics manufacturers and TSMT (Taiwan Surface Mounting Technology) to create the best user friendly product- Temp Pal® All their team members are parents and expecting couples, who have experienced the morning hassle of checking BBT (Basic Body Temperature) chart and sleeplessnights worrying about child fever. That’s why they put their engineering and medical expertise to developing Temp Pal®, a device designed to make temperature monitoring easier and more comfortable.

NEWS Nurturing Stalwarts of Future Industries Taiwan us [...]

Investment focus

Biotechnology, Software, Artificial Intelligence
Series A, Series B, Seed
United States, Taiwan, United Kingdom

Portfolio highlights

DataPelago — DataPelago provides big data analytics solutions. They also provide a data analytics platform that offers hardware and software based products. The platform also provides solutions for extracting insights from data of, speed, or structure at performance and cost levels unsurpassed in the industry.
Path Robotics — We create manufacturing robots that autonomously scan, position, and weld your parts without the need for skilled welders or robot programmers.
ARRIS — Using next-gen advanced manufacturing technologies, ARRIS Composites produces smarter, lighter, stronger, and more sustainable products at scale.

BE Health Ventures is a boutique advisory and investment company, specializing in technologies, financials and healthcare industries.

Investment focus

Medical, Health Care, 3D Printing
Seed, Series B
Taiwan, Thailand

Portfolio highlights

Meticuly — Meticuly is a global leader in 3D printed patient specific implant. We use cutting-edge technology to create precise, customized implants for improved patient care. Visit to learn more!
Iweecare — Founded in Taiwan Taipei 2014, iWEECARE is collaborating with electronics manufacturers and TSMT (Taiwan Surface Mounting Technology) to create the best user friendly product- Temp Pal® All their team members are parents and expecting couples, who have experienced the morning hassle of checking BBT (Basic Body Temperature) chart and sleeplessnights worrying about child fever. That’s why they put their engineering and medical expertise to developing Temp Pal®, a device designed to make temperature monitoring easier and more comfortable.

Biomark Capital provides venture funding and assistance to early, mid, and late-stage life science companies. We target companies with novel approaches to diagnostics, therapeutics, medical devices, and digital health that will change the face of healthcare innovation in the future. We share the drive and vision of our portfolio companies tocollaborate with them in accelerating growth and building successful business ventures.

Investment focus

Health Care, Biotechnology, Medical
Funding Round, Series A, Series E
Taiwan, United States

Portfolio highlights

i2Dx —
Eden Biologics — Eden Biologics, formerly known as JHL Biotech ("JHL") , is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners through the provision of contract development and manufacturing services. We are specialists in manufacturing biologics, from cell line development tocommercial manufacturing with both global and regional regulatory affairs expertise.
WhiteGlove Health —

CCIC CDIB International Corp.

Investment focus

Health Care, Biotechnology, Information Technology
Series B, Series A, Series C
Taiwan, China, United States

Portfolio highlights

QT Medical — World's leading medical ECG/EKG machine company that aims to make hospital-grade 12-lead ecg machines available for everyone. Best portable ecg device during the pandemic. Focusing on innovations in the field of telemedicine and home care, we continue to invest in research and development of products that will bring better cardiac care to patients.
Micronbrane Medical — A number exacerbated by the low sensitivity and yield of traditional diagnostic methods.
Beijing Ansong Technology — Beijing Ansong Technology Co., Ltd. is an enterprise focusing on the research and development, production, and sales of orthopedic medical devices. The company cooperates with domestic and foreign universities, research institutes, and doctors in hospitals, and is committed to creating original orthopedic products with independent knowledgeproducts.Beijing Ansong Technology was founded on June 27, 2011 by Liang Tao in Fengtai, Beijing.

DCI Partners is a venture capital firm specializing in the fields of drug discovery and regenerative medicine.

Investment focus

Health Care, Medical, Biotechnology
Series A, Funding Round, Series B
Japan, Taiwan

Portfolio highlights

K Pharma — K Pharma Is the development Of the Treatment Of the Spinal Cord injury
Renascience — Renascience is a pharmaceuticals company.
Elixiron Immunotherapeutics — Elixiron Immunotherapeutics is a company developing therapeutics for cancer, neurological diseases, and inflammatory disorders.

Mega International Commercial Bank is a result of the merger of International Commercial Bank of China and Chiao Tung Bank.

Investment focus

Banking, Payments, Biotechnology
Series A, Debt Financing
Taiwan, Philippines

Portfolio highlights

China Bank — At China Bank, we are committed to making your success our business. We offer a complete range of deposit, investment, financing, remittance, and insurance products and services, accessible through our vast network of branches nationwide and secure and reliable electronic banking channels: China Bank TellerCard (ATM), China Bank Online (internet& mobile banking) and China Bank Tellerphone (phone banking)
Elixiron Immunotherapeutics — Elixiron Immunotherapeutics is a company developing therapeutics for cancer, neurological diseases, and inflammatory disorders.

Pangu Venture Capital a venture capital firm specializing in the Internet, life sciences, cleantech, artificial intelligence, and culture

Investment focus

Biotechnology, Apps, SaaS
Series A, Seed, Angel
China, Taiwan, United States

Portfolio highlights

AutoBrain — AutoBrain focuses on the research and development of advanced and intelligent automatic driving systems.
No. 1 workplace — No.1 workplace is a workplace service platform. It helps companies and candidates to achieve job matching through AI technology.
Elixiron Immunotherapeutics — Elixiron Immunotherapeutics is a company developing therapeutics for cancer, neurological diseases, and inflammatory disorders.

Bill Chang

Investment focus

Genetics, Software, Health Care
Series A
Taiwan

Portfolio highlights

ATGENOMIX — ATGENOMIX is a specialist next generation sequencing and enterprise-grade complete Bio-IT platform for accelerating genomic data processing with accuracy, scalability and reliability.

TaiAn Technologies Corporation is a technology advisory company that specializes in commercializing intellectual properties in the life sciences. Our team comprised of numerous biomedical experts that work closely with investment professionals to support up-and-coming life science technologies. Most importantly, we are entrusted by our shareholdersto explore technology platforms in the life sciences arena, to build upon the novel technologies, and to transform them into viable business opportunities supporting existing or creating new entities. Our shareholders comprised of Development Fund of the Executive Yuan of Taiwan as well as numerous conglomerates that are recognized in Taiwan and internationally well known. Leveraging our shareholders/ partners' resources and our strong management team, our multiplex services create synergies with Taiwanese corporations and add significant value to your company.

Investment focus

Biotechnology, Medical, Therapeutics
Series A, Series B
Taiwan, United States

Portfolio highlights

AnBogen Therapeutics — Harness the Power of Science to Cure Cancer.
APRINOIA Therapeutics — APRINOIA Therapeutics specializes in the diagnotics and therapeutics for Alzheimer's disease and tauopathies.Aprinoia Therapeutics is dedicated to establish a drug discovery and early development company that is based on innovation and scientific rigor and integrity. Its goal is to create novel products to meet critical patient needs,including: 1) Novel imaging-based diagnostic tools to improve the detection of occurrence, progression, and regression of neurological diseases; and 2) Novel therapies to improve the treatment of human neurological conditions.
Sapience Therapeutics — Sapience Therapeutics is a preclinical-stage biotechnology company focused on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers. Our drug development program involves translating science into novel therapies, and our initial goal is to develop a first-in-class treatment for glioblastoma multiforme(GBM), which is the most severe and deadly form of brain cancer.The company was founded in 2015 by Barry Kappel and is based in Scarsdale, New York, United States.

PT Lippo Karawaci Tbk ("Lippo Karawaci") was founded on a vision to impact lives through the development of well-planned sustainable independent townships within green environments and first class physical and social infrastructure. Over more than a decade, the Company has proven itself to be a highly trusted property developer with amost recognisable brand name. It is the owner of the largest diversified landbank and a leader in pioneering projects in strategic locations throughout Indonesia. Through a merger of 8 property related companies in 2004 the Company has expanded its business portfolio to encompass urban development, large scale integrated developments, retail malls, healthcare, hotels and leisure, as well as a fee-based income portfolio.Lippo Karawaci is now the largest listed property company in Indonesia by market capitalisation, assets and revenue, with a unique and integrated business model. It operates Indonesia’s premier private hospital group, the only one achieving world class standards, and is an undisputed retail property industry leader.

Investment focus

Internet, E-Commerce, FinTech
Seed, Series A, Funding Round
United States, Singapore, China

Portfolio highlights

Tencent — Tencent is an internet service portal offering value-added internet, mobile, telecom, and online advertising services. Its communications and social platforms Weixin and QQ connect users with each other, with digital content and daily life services in just a few clicks. Tencent has maintained steady growth under its user-oriented operatingstrategies. It provides value-added internet, mobile, and telecom services, as well as online advertising under the strategic goal of providing users with "one-stop online lifestyle services." Tencent’s Internet platforms in China – QQ (QQ Instant Messenger), WeChat, QQ.com, QQ Games, Qzone, 3g.QQ.com, SoSo, PaiPai, and Tenpay – aim to address the various needs of internet users, including communication, information, entertainment, e-commerce, and others.In September 2013, Tencent's market valuation rose to $101 billion, and as of November 21, 2013, QQ had 2 billion active users and WeChat had 650 million monthly active users. The numbers of active users for QQ mail, Qzone, Tencent Weibo, and QQ news were 274 million, 626 million, 220 million, and 150 million, respectively.Tencent was founded in November of 1998. In April 2000, the IDG and PCCW invested a total of $2.2 million dollars in the company. Tencent was listed on the Hong Kong Stock Exchange (SEHK) on June 16, 2004. Baidu, Alibaba, and Netease are Tencent's major competitors.
Fairbanc — Fairbanc is a scalable, AI-powered mobile loan and payments platform for emerging market small-medium enterprises (SMEs) that requires no collateral or credit history.The company's AI-powered platform can read digital footprints such as transaction history with large suppliers, and data on the mobile phone to grant instant digital creditline that SMEs can use to purchase inventories from our selected suppliers. Fairbanc's proven gender-intelligent ecosystem for loans and payments can be used in many vertical markets, eliminating the shortcomings of cash. Retail shop-owners can boost sales up to 20%, eliminate cash shortages, enjoy an easier payments regimen, and develop a credit history; suppliers receive more consistent order cycles, more instant payments upon delivery, and SKU sales expansion.
MoolahGo — Digital payment services conveniently packaged in one single app

TMI Holding Corp. is a Taipei-based, institutionalized angel investment firm that funds internet and mobile startups.

Investment focus

Life Science, Consumer, Software
Series D, Funding Round
Taiwan, United States

Portfolio highlights

SmartAnalyst — SmartAnalyst offers Strategic Decision Analysis Solutions, HEOR Solutions and Subscription Insights Solutions to support Bio-Pharma Innovation and Technology
R+W Studios — R+W is a global agency & startup incubator based in Hong Kong, Taipei, New York and Washington DC.

John Hsuan

Investment focus

Medical, Health Care, Biotechnology
Series A, Series B
Taiwan

Portfolio highlights

Hukui Bio — Founded in November 2013, HuKui Bio provides total solution and value-added services to global medical devices customers. By focusing on medical electronics and handheld devices for digital healthcare and telemedicine, we do the designing and development in Taiwan, manufacturing in Asia, and delivering our sales & services globally. Combiningseasoned experts and investors from biomedical, tech, and financial industries, we strive to be the best partner in the Asia-Pacific region for MedTech developers, startups and corporates by completing projects on-time, on-budget and by meeting global quality standards concurrently. Our US company, HuKui Tech, is a subsidiary based in the Bay area, 100% owned by HuKui Bio since 2020.

Investors by industry

Artificial intelligence